The British Journal of Psychiatry 139: 16-22 (1981)
© 1981 The Royal College of Psychiatrists
Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medication
F Owen, RC Bourne, TJ Crow, AA Fadhli and EC Johnstone
Platelet MAO activity was assessed in 35 schizophrenics during a trial of
the isomers of flupenthixol. Enzyme activity was unrelated to severity of
symptoms, the presence of delusions, hallucinations or thought disorder or
to negative symptoms. In a few patients MAO activity fluctuated widely with
time, but in the group of patients on medication there was a slow decrease
in enzyme activity which was significant after 28 days of treatment. Enzyme
activity after 14 days' drug treatment was still correlated with activity
before treatment, but after 28 days this significant correlation
disappeared. Slow effects of neuroleptic drugs on platelet MAO activity may
explain previous findings of reduced activity of the enzyme in
schizophrenia.